Rene Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 05-07-2024
- Paid Up Capital ₹ 1.00 M
as on 05-07-2024
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.32 Cr
as on 05-07-2024
- Satisfied Charges ₹ 3.30 Cr
as on 05-07-2024
- Revenue -23.29%
(FY 2022)
- Profit -19.20%
(FY 2022)
- Ebitda -27.02%
(FY 2022)
- Net Worth 17.92%
(FY 2022)
- Total Assets -2.57%
(FY 2022)
About Rene Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.32 Cr. The company has closed loans amounting to ₹3.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Narendra Shelar and Nalamati Arun serve as directors at the Company.
- CIN/LLPIN
U51101MH2016PTC274524
- Company No.
274524
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Mar 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Rene Pharmaceuticals Private Limited offer?
Rene Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine, Cardiovascular Drugs & Medication, Blood Pressure Medicine, Kidney Drugs, Antibiotic Tablets & Capsules, Cefixime Tablet, Cilnidipine Tablets, Cardiac Drugs, Anti Inflammatory Drugs.
Who are the key members and board of directors at Rene Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narendra Shelar  | Managing Director | 17-Mar-2016 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nalamati Arun | Director | 23-Aug-2016 | Current |
Financial Performance of Rene Pharmaceuticals.
Rene Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 23.29% decrease. The company also saw a substantial fall in profitability, with a 19.2% decrease in profit. The company's net worth Soared by an impressive increase of 17.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rene Pharmaceuticals?
In 2022, Rene Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 05 Jan 2024 | ₹2.00 Cr | Open |
Hdfc Bank Limited Creation Date: 21 Oct 2023 | ₹3.16 M | Open |
Axis Bank Limited Creation Date: 25 Jan 2022 | ₹1.65 Cr | Satisfied |
How Many Employees Work at Rene Pharmaceuticals?
Rene Pharmaceuticals has a workforce of 27 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rene Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rene Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
